Fontainhas Aurora M, Townes-Anderson Ellen
Program of Integrative Neuroscience, UMDNJ-Graduate School in Biomedical Sciences and Rutgers University, Newark, New Jersey, USA.
Invest Ophthalmol Vis Sci. 2008 Sep;49(9):4177-87. doi: 10.1167/iovs.07-1580. Epub 2008 May 23.
Adult salamander photoreceptors retract existing axons and extend new neuritic processes in vitro. In mammalian retina, similar forms of structural plasticity occur in injury and disease. The authors asked whether RhoA is present in photoreceptor axon terminals and whether activity in the RhoA-ROCK pathway contributes to the structural plasticity observed in rod and cone cells.
Antibodies against RhoA were used to immunolabel Western blots sections and isolated neurons from salamander retina. Isolated photoreceptors were treated with lysophosphatidic acid (LPA; a RhoA activator) or Y27632 (an inhibitor of RhoA effector ROCK) for the first 24 hours, the first 3 days, or the last 24 hours of culture. Growth and retraction were assessed with time-lapse and image analyses.
RhoA protein was found throughout the retina, including in rod and cone synaptic terminals. When treated with LPA, photoreceptors significantly reduced the growth of new neuritic processes and presynaptic varicosities and retracted growth at the highest LPA concentrations. When treated with Y27632, rod cells significantly increased the number of varicosities, whereas cone cells increased process growth. Treatment with Y27632 also dramatically reduced retraction of the existing axon, which occurs spontaneously in rod cells during the first 24 hours of culture.
Thus, RhoA-ROCK activity reduces and retracts neuritic growth, but inhibition of activity increases neuritic development and blocks retraction. The results suggest that RhoA activation contributes to axon retraction by rod cells after retinal detachment, whereas inhibition of RhoA contributes to the neuritic sprouting seen in reattached and degenerating retina.
成年蝾螈光感受器在体外会回缩现有的轴突并延伸新的神经突。在哺乳动物视网膜中,类似形式的结构可塑性在损伤和疾病中出现。作者研究了RhoA是否存在于光感受器轴突终末,以及RhoA-ROCK通路的活性是否有助于在视杆和视锥细胞中观察到的结构可塑性。
使用抗RhoA抗体对来自蝾螈视网膜的蛋白质免疫印迹切片和分离的神经元进行免疫标记。在培养的前24小时、前3天或最后24小时,对分离的光感受器用溶血磷脂酸(LPA;一种RhoA激活剂)或Y27632(一种RhoA效应器ROCK的抑制剂)进行处理。通过延时和图像分析评估生长和回缩情况。
在整个视网膜中都发现了RhoA蛋白,包括在视杆和视锥突触终末。用LPA处理时,光感受器显著减少了新神经突的生长和突触前膨体,并且在最高LPA浓度下回缩生长。用Y27632处理时,视杆细胞显著增加了膨体的数量,而视锥细胞增加了突起的生长。用Y27632处理还显著减少了现有轴突的回缩,这种回缩在培养的前24小时在视杆细胞中自发发生。
因此,RhoA-ROCK活性减少并回缩神经突生长,但抑制该活性会增加神经突发育并阻止回缩。结果表明,RhoA激活有助于视网膜脱离后视杆细胞的轴突回缩,而抑制RhoA有助于在重新附着和退化的视网膜中观察到的神经突萌发。